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Objective: To describe medical abortion (MA) practices among private providers in 
Vietnam.
Methods: The study subjects were women (n = 258) undergoing early MA through 12 private 
providers in Hanoi during February−June 2012. The women were interviewed on the day of their 
procedure and were followed up by telephone 14 days after mifepristone administration.
Results: Of the 258 women in the study, 97% used a regimen of mifepristone plus misoprostol; 
80% were instructed to administer misoprostol at home. MA resulted in a complete termination 
in 90.8% of cases. All women were provided with information on potential complications and 
were instructed to return for a follow-up visit. We successfully followed up 77.5% (n = 200) of 
participants by telephone, while nearly two-thirds of women returned to the clinic for a follow-
up visit. At follow-up, 39.5% of women reported having used a Help line service, while 7% 
had sought help from a health provider. A high unmet need for postabortion family planning 
was identified.
Conclusion: Follow-up of women, postabortion care, and the provision of family planning 
have been identified as important areas to address for strengthening MA services in the private 
sector in Vietnam.
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Introduction
Medical abortion (MA) provides an important alternative to surgical methods for the 
termination of pregnancy.1 The combination of 200 mg oral mifepristone followed 
by 0.8 mg misoprostol administered vaginally, buccally, or sublingually 24–48 hours 
later (or 0.4 mg oral misoprostol for pregnancies #49 days) has been recommended 
by the World Health Organization (WHO) for the termination of pregnancies of up to 
63-days gestational age.2 In previous studies, this regimen has been shown to result 
in complete abortion in more than 96% of cases.3
MA was introduced into sexual and reproductive health services in Vietnam in 
1992,4 and the regimen of 200 mg mifepristone and 0.4 mg oral misoprostol has 
subsequently been shown to be effective (complete abortion .93%) and acceptable 
(.90%) among Vietnamese women, in clinical trials.5,6 The administration of miso-
prostol at home has been shown to result in similar rates of complete abortion and 
acceptability to those of clinic-based procedures,6 indicating that home-based MA is 
a safe and feasible option in the Vietnamese health care setting.7
In Vietnam, MA can be legally administered by trained physicians in public hos-
pitals for pregnancies of up to 9-weeks gestation (different gestational limits apply 
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at different levels of the health system).4 Private providers 
with appropriate training may provide MA services for 
pregnancies up to 6-weeks gestation. Poor perceived qual-
ity of services in the public sector means that Vietnamese 
women often access the private sector for reproductive health 
services.8 For example, Marie Stopes International Vietnam 
(MSIVN), a nonprofit organization specializing in sexual 
and reproductive health services, provided MA services to 
an estimated 88,500 clients in 2011, through its clinics and 
BlueStar social franchising network.9 However, there is no 
centralized system for monitoring the number and quality 
of MA procedures that take place in the private sector, and 
services are largely unregulated.4,10 Therefore, despite the 
widespread nature of private provision, little is known about 
the current practices and support mechanisms in place for 
women using MA, particularly those administering miso-
prostol at home.
We conducted an evaluation to describe MA practices 
among private providers in Vietnam. A secondary objective 
was to assess whether women using home-based MA can be 
followed up using telephone.
Methods
We followed up women undergoing MA at 12 private health 
providers in Hanoi, Vietnam. The providers were identified 
through MSIVN’s network of BlueStar social franchisees. Of 
the 40 clinics identified in Hanoi that provided MA services 
and that were willing to participate in the evaluation, 12 were 
randomly selected for inclusion in the study (using a random 
number generator and a prespecified list). The study clinics 
were located in the Ba Dinh, Dong Da, Tu Liem, Gia Lam, 
Ha Dong, and Hai Ba Trung districts in Hanoi. All women 
aged 18–49 years seeking MA for first trimester pregnan-
cies at these clinics between February 2012 and June 2012 
were invited to participate in the study. Women who met the 
following criteria were included: gestational age ,9 weeks, 
no medical contraindications or allergies to MA medication, 
intrauterine pregnancy, willing to be followed up, and able 
to provide informed consent. The research protocol was 
approved by the Ethics Review Committee at the Hanoi 
School of Public Health.
study procedure
Informed consent was sought from all women who were 
eligible for participation in the study. Clinic staff interviewed 
consenting women prior to the MA procedure (baseline) 
using a structured questionnaire, to collect information on 
sociodemographic characteristics and reproductive history. 
Women underwent the MA procedure according to the 
clinic’s standard practice (a separate study protocol was 
not specified in order to enable the assessment of the exist-
ing clinic practices). Information about the procedure and 
additional clinical information was extracted by clinic staff 
(in most cases, the clinic receptionist) from medical records, 
using a predesigned paper-based form. The following data 
were extracted: the method used to determine gestational 
age, the gestational age, and the MA drug regimen. Infor-
mation on the provider experience was assessed using a 
short, self-administered questionnaire that was completed 
by doctors participating in the study. Women were followed 
up at 14 days after the administration of mifepristone, with a 
telephone questionnaire conducted by trained interviewers. 
If a woman could not be reached on day 14, daily attempts 
(one telephone call per day) were made to contact her, up 
to day 20; as specified in the study protocol, women were 
reminded at each contact that they had the right to refuse or 
to stop the interview at any time, without any implications 
for the services they received from MSIVN or the govern-
ment. Participants were offered a small incentive in the 
form of mobile phone credit (1 USD) for participation in 
the follow-up interview. The follow-up interview collected 
information on the MA procedure, outcome of the procedure, 
side effects, postabortion services, and women’s satisfaction 
with services. On day 20, information from any follow-up 
visit to the clinic was extracted from clinic records (outcome 
of procedure and any interventions used, eg, additional MA 
drugs administered or surgical intervention for incomplete 
abortion).
Data analysis
Descriptive statistics (frequencies, proportions, means, 
and standard deviations) were used to summarize the pro-
cedures used by the private providers, the proportion of 
women followed up by telephone and at the clinic, and the 
clinical outcomes of MA (complete termination, retained 
products or ongoing pregnancy, and side effects and other 
complications). Differences in the outcomes, by women’s 
sociodemographic and reproductive characteristics, were 
assessed using chi-squared tests for categorical variables 
and t-tests for continuous variables. All statistical analyses 
were carried out using Stata 12.1 (StataCorp LP, College 
Station, TX, USA).
Results
A total of 330 women were invited to participate in the 
study. Of these, 258 women (response rate 78%) responded 
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to the baseline questionnaire. At the telephone follow-up 
14–20 days later, 200 women (77.5%) responded. The 
remaining 58 women could not be contacted, despite daily 
attempts up to day 20.
The baseline characteristics of the study population are 
presented in Table 1. There were no statistically significant 
differences in the sociodemographic or reproductive char-
acteristics between the women who were followed up and 
those who were not (at conventional levels of significance, 
P , 0.05). However, 82% of women who were prescribed 
painkillers (n = 175 of 213) were followed up compared 
with just 55% of women who were not prescribed painkill-
ers (n = 25 of 45) (P , 0.001 from chi-squared test for the 
difference in proportions).
Ma provision characteristics
Doctors had an average of 3.9 (± 2.26) years of experience 
in the provision of MA (range 1–10 years) and carried out 
61.1 abortion procedures (medical or surgical) per month. 
A combination of mifepristone (Mifestad 200; STADA, Bad 
Vilbel, Germany) and misoprostol was used in 97% of cases 
(routes of misoprostol administration were: 43% sublingual, 
34% oral, 23% buccal, and 20% vaginal). The combina-
tion of methotrexate and misoprostol was used among 
the remaining 3%. The majority of women (80%) were 
instructed by the provider to administer misoprostol at home. 
Two-thirds of providers (65%) required the woman to live 
within 30 minutes travel time from the clinic in order to be 
eligible for MA, and all providers advised women to return 
for a follow-up visit within 2 weeks. All the facilities had 
postabortion family planning services; all facilities offered 
intrauterine device (IUD) insertion, 88% also offered the oral 
pill, 65% had condoms, 43% injectables, and 18% implants. 
Just 3% of facilities offered male sterilization, while none 
offered female sterilization.
advice and counseling
Among the participants (n = 200), 94% reported that they 
were provided with information about the signs of compli-
cations following their MA procedure, and all respondents 
received a contact number for a Help line. The majority of 
women (81%, n = 162) were informed about where to go in 
case of complications. Of these, 84.6% were told to return 
to the clinic, while the remaining women were advised to 
go to the nearest hospital or health care facility. Nearly 
two-thirds of women (64%) received advice on postabortion 
family planning.
Outcomes of Ma procedure
The outcomes of the MA procedure are shown in Table 2. The 
most common self-reported side effects of MA were bleeding, 
pain, diarrhea, fever/chills, and vomiting. More than a third 
of women reported using the Help line number; the reasons 
for calling the Help line included heavy bleeding (34.2% 
of 79 women), pain (34.2%), not observing signs of MA as 
described by the doctor (13.9%), vomiting (11.4%), discom-
fort (10.1%), and prolonged bleeding (7.6%). A small number 
Table 1 Baseline characteristics of women accessing early 
medical abortion services at 12 private clinics in Hanoi, Vietnam, 
between February and June 2012
Characteristic Baseline 
% (n)a 
n = 258
age (years)
 range 18−48
 Mean (sD) 26.4 (± 5.59)
Highest education level
 Middle school 14.3 (37)
 High school 37.2 (96)
 Vocational training 26.7 (69)
 University and above 21.7 (56)
Occupation
 Housewife or farmer 14.3 (37)
 small sales or services 11.2 (29)
 student 14.3 (37)
 Worker 27.9 (72)
 clerical or business 28.7 (74)
 Other 3.5 (9)
Marital status
 Married and living with husband 67.8 (175)
 separated/divorced/widowed 0.4 (1)
 single 31.8 (82)
number of pregnancies
 range 1–10
 Mean (sD) 2.6 (± 1.82)
 Previous termination 48.1 (124)
  Previous surgical abortion 34.9 (90)
  Previous medical abortion 21.7 (56)
Method used to determine gestational age
 Bimanual examination 1.2 (3)
 Ultrasound 98.8 (255)
 gestational age in weeks
  range 4−7
  Mean (sD) 5.3 (0.79)
Medical abortion drug regimen
 Mifepristone + misoprostol 96.9 (250)
 Methotrexate + misoprostol 3.1 (8)
Place of misoprostol administration
 clinic 20.2 (52)
 Home 79.8 (206)
analgesics prescribed 82.6 (213)
Note: aUnless specified.
Abbreviation: sD, standard deviation.
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of women reported seeking help from a health provider, mostly 
for heavy or prolonged bleeding and pain. Just one woman 
reported seeking help for a fever. Of the women who sought 
help, 43% underwent a surgical procedure, while 21% were 
given additional doses of misoprostol; the remaining women 
did not report receiving any additional intervention.
Women who had a previous termination were less likely to 
return for their follow-up visit than were women who had not 
had a previous termination (58% versus 72%) (P = 0.041), 
as were women who had misoprostol administered at the 
clinic (42%) versus women who administered misoprostol at 
home (71%) (P = 0.001). However, there was no difference 
in follow-up according to the type of abortion (medical or 
surgical) that the woman had experienced previously.
MA resulted in a complete termination in 90.8% of cases; 
the MA outcome was not associated with any sociodemo-
graphic or clinical characteristics. In the cases of incomplete 
abortion (n = 18), 80% of women went on to have a surgi-
cal intervention, while 11% were given additional doses of 
misoprostol.
After the MA procedure, 40% of women reported that 
they had adopted a family planning method. The uptake of 
postabortion family planning was not predicted by any of the 
sociodemographic, reproductive, or clinical characteristics 
listed in Table 1. However, 48% of women who were coun-
seled on postabortion family planning adopted a method 
compared with just 26% of women who did not receive any 
counseling (P = 0.002). Of the women who did not adopt a 
family planning method (n = 118), 93% reported that they 
would like one.
acceptability of Ma procedure
Nearly all respondents (97%) reported that they were satis-
fied or very satisfied with their MA procedure, 77% stated 
that they would use the method again if they needed another 
termination, and 87% would recommend the method to a 
friend if she needed a termination.
Discussion
This evaluation has shown that the combination of mifepri-
stone and misoprostol, with the home-based administration 
of misoprostol, is the most commonly used MA regimen 
among the private providers included in this study. The MA 
prescribed by these providers resulted in a complete termina-
tion of pregnancy in 91% of cases. More than three-quarters 
of women who accessed these services could be followed up 
by telephone, and nearly two-thirds returned to the clinic for a 
follow-up visit. Women were less likely to attend the follow-
up visit if they had had a previous termination (medical or 
surgical) or a clinic-based MA procedure.
This study has some limitations that influence the inter-
pretation of the findings. The clinics that were recruited to 
the study were part of a social franchise network with stan-
dardized procedures and quality requirements. It may be the 
case that the services provided at these clinics are not typical 
of other private providers, and the measures of safety and 
acceptability may be more variable than were indicated by 
our findings. Additionally, this study was conducted among 
a small number of providers located in urban settings in 
Hanoi; therefore, it is not possible to generalize our findings 
to rural settings, where health providers and women may be 
more difficult to access. We assessed clinic outcomes up 
to 3 weeks after the MA procedure; although it would be 
expected that most women would attend the clinic within 
this time, a longer period of follow-up might have captured 
data on more women. Furthermore, the women who could 
not be contacted for a follow-up interview may have attended 
another clinic for an in-person visit, which would not have 
been captured in our study.
Due to the difficulties in regulating MA procedures in the 
expanding private sector in Vietnam, there has been concern 
about the quality of services available to women, including 
Table 2 Outcomes and side effects reported by women following 
early medical abortion at 12 private clinics in Hanoi, Vietnam, 
between February 2012 and June 2012
Outcomes % (n) 
n = 200
self-reported side effects of misoprostol
 Heavy or prolonged bleeding 90.0 (180)
 Pain 82.5 (165)
 Diarrhea 29.0 (58)
 Fever/chills 15.0 (30)
 Vomiting 13.5 (27)
Used contact number for Help line 39.5 (79)
sought help from a health provider 7.0 (14)
returned to clinic for follow-up 65.5 (131)
Method used to determine outcome of Ma procedure
 Pregnancy test at clinic 2.0 (4)
 Ultrasound at clinic 68.0 (136)
 Pregnancy test at home 28.5 (57)
 Have not checked 1.5 (3)
Outcome of Ma procedure
 complete termination 90.8 (177)
 retained products 8.7 (17)
 Ongoing pregnancy 0.5 (1)
 Has adopted a family planning method since Ma 
procedure
40.5 (81)
 among those who did not adopt family planning  
(n = 118), would have liked one
93.2 (110)
Abbreviation: Ma, medical abortion.
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reservations about training and safety.11 The effectiveness 
of MA observed in this study (91%) is low in comparison 
with the efficacy rates reported in trials of clinic-based MA 
regimens.3 However, the effectiveness is comparable with 
rates reported in previous studies of home-based MA regi-
mens.12 It may be the case that rates of incomplete abortion 
are relatively high because when women present at clinics 
with concerns, providers prefer to intervene using surgical 
or medical methods rather than having women wait for the 
procedure to complete itself. The high proportions of women 
who experienced side effects are similar to those observed 
in other studies3 and highlight the importance of counseling 
to prepare women for what MA procedures entail. Our study 
has shown that most women were informed about what to 
do in the case of complications, and sources of advice, such 
as the MSIVN Help line appear to be important resources 
for women.
Telephone consultation has been identified as an alterna-
tive to follow-up visits after MA,13 which may reduce the 
barriers to service access and provision. We have shown 
that a moderately high proportion of women (78%) can be 
reached by telephone in this setting, where the majority 
of MA procedures have involved the home-based admin-
istration of misoprostol. Women who previously had an 
abortion were less likely to attend the clinic for follow-up; 
one explanation for this may be that women with prior 
experience were aware of the usual progression of a medical 
termination procedure and the signs of complete abortion, 
and did not feel the need for confirmation from a clinician. 
The lower rate of follow-up among women who underwent 
a MA procedure with clinic-based administration of both 
mifepristone and misoprostol lends further support to this 
interpretation, as women may have been more reassured 
about the outcome of the procedure if administered under 
medical supervision. Although we have no data on the 
MA outcomes for women lost to follow-up, other studies 
have indicated that women’s observations, together with 
a pregnancy test or other method of clinical examination, 
can be used for accurate assessment of MA outcomes.13,14 
Further qualitative research may identify the reasons why 
women do not wish to attend follow-up visits  after MA 
and suggest alternative methods of follow-up that are more 
acceptable to women.
We have identified a low provision of postabortion family 
planning and a large unmet need for family planning among 
women seeking MA through these private providers; nearly 
all of the women who did not go on to adopt a family plan-
ning method after their MA procedure expressed a desire to 
use a method. The women who received counseling on fam-
ily planning were more likely to adopt a method than those 
who did not have counseling. This indicates that postabortion 
family planning services should be strengthened among these 
providers, with MA counseling providing an opportunity for 
the discussion of family planning options and services.
The findings of this study indicate that women using MA 
services offered by private providers can be reached by tele-
phone, while a telephone Help line is an important support 
mechanism for women undergoing MA. Telephone-based 
systems of monitoring are likely to be particularly important 
where a high number of procedures involve the administration 
of misoprostol at home. There is increasing evidence from 
Latin American countries15,16 and anecdotal evidence from 
Vietnam that women frequently access and self-administer 
MA drugs through pharmacies; pharmacies and other providers 
could feasibly use telephone services to provide support to and 
monitor women who might otherwise be lost to follow-up.
Even in a country such as Vietnam, where legal abortion is 
available on request, women experience structural barriers to 
accessing services;17 therefore, the provision of MA through 
private providers is one important way of expanding access 
to safe abortion. Improving the follow-up of women, MA 
counseling, and postabortion family planning services have 
all been identified as important areas for strengthening MA 
services in the private sector.
Disclosure
The authors (MHP, THN, AND, and TDN) work for Marie 
Stopes International, an organization that provides medical 
abortion procedures in the United Kingdom and globally. The 
authors report no other conflicts of interest in this work.
References
1. Creinin MD. Medical abortion regimens: historical context and overview. 
Am J Obstet Gynecol. 2000;183(Suppl 2):S3–S9.
2. World Health Organization. Safe Abortion: Technical and Policy 
Guidance for Health Systems. 2nd ed. Geneva: World Health 
Organization; 2012.
3. Kulier R, Kapp N, Gülmezoglu AM, Hofmeyr GJ, Cheng L, Campana A. 
Medical methods for first trimester abortion [review]. Cochrane Database 
Syst Rev. 2011;9(11):CD002855.
4. Ganatra B, Bygdeman M, Phan BT, Nguyen DV, Vu ML. From research 
to reality: the challenges of introducing medical abortion into service 
delivery in Vietnam. Reprod Health Matters. 2004;12(Suppl 24): 
S105–S113.
5. Elul B, Hajri S, Ngoc NN, et al. Can women in less-developed countries 
use a simplified medical abortion regimen? Lancet. 2001;357(9266): 
1402–1405.
6. Ngoc NT, Nhan VQ, Blum J, Mai TT, Durocher JM, Winikoff B. Is 
home-based administration of prostaglandin safe and feasible for 
medical abortion? Results from a multisite study in Vietnam. BJOG. 
2004;111(8):814–819.
International Journal of Women’s Health
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-womens-health-journal
The International Journal of Women’s Health is an international, peer-
reviewed open-access journal publishing original research, reports, 
editorials, reviews and commentaries on all aspects of women’s 
healthcare including gynecology, obstetrics, and breast cancer. The 
manuscript management system is completely online and includes 
a very quick and fair peer-review system, which is all easy to use. 
Visit http://www.dovepress.com/testimonials.php to read real quotes 
from published authors.
International Journal of Women’s Health 2013:5submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
598
Park et al
 7. Ho PC. Women’s perceptions on medical abortion. Contraception. 
2006;74(1):11–15.
 8. Ha NT, Berman P, Larsen U. Household utilization and expenditure 
on private and public health services in Vietnam. Health Policy Plan. 
2002;17(1):61–70.
 9. Fry K, Hopkins K, May K. The Global Impact Report 2011. Delivering 
Choice and Rights for Women: Past, Present and Future. London: Marie 
Stopes International; 2012.
 10. Vietnam Ministry of Health. Joint Annual Health Review 2010: 
Vietnam’s Health System on the Threshold of the Five-year Plan 
2011−2015. Hanoi: [Vietnam] Ministry of Health; 2010. Available 
from: http://jahr.org.vn/downloads/JAHR2010-EN.pdf. Accessed July 
2, 2013.
 11. Raghavan S, Ngoc Nt, Shochet T, Winikoff B. Clinic-level intro-
duction of medical abortion in Vietnam. Int J Gynaecol Obstet. 
2012;119(1):39–43.
 12. Ngo TD, Park MH, Shakur H, Free C. Comparative effectiveness, 
safety and acceptability of medical abortion at home and in a clinic: 
a systematic review. Bull World Health Organ. 2011;89(5):360–370.
 13. Grossman D, Grindlay K. Alternatives to ultrasound for follow-up after 
medication abortion: a systematic review. Contraception. 2011;83(6): 
504–510.
 14. Jackson AV, Dayananda I, Fortin JM, Fitzmaurice G, Goldberg AB. 
Can women accurately assess the outcome of medical abortion based 
on symptoms alone? Contraception. 2012;85(2):192–197.
 15. Lara D, Abuabara K, Grossman D, Díaz-Olavarrieta C. Pharmacy 
provision of medical abortifacients in a Latin American city. 
Contraception. 2006;74(5):394–399.
 16. Billings DL, Walker D, Mainero del Paso G, Clark KA, Dayananda I. 
Pharmacy worker practices related to use of misoprostol for abortion 
in one Mexican state. Contraception. 2009;79(6):445–451.
 17. Gallo MF, Nghia NC. Real life is different: a qualitative study of why 
women delay abortion until the second trimester in Vietnam. Soc Sci 
Med. 2007;64(9):1812–1822.
